Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous versus on-demand levocetirizine for persistent allergic rhinitis over 6 months
2004-003858-26Phase 4Completed
- Sponsor
- UCB
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levocetirizine in allergic rhinitis (AR) (2 arms), sponsored by UCB. Started Aug 2005; status: completed.
02
Drugs
levocetirizine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2004-003858-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003858-26.